CC Chemokine ligand 17 in periodontal diseases: Expression in diseased tissues and production by human gingival fibroblasts

Journal of Periodontal Research

Volumn 43, Issue 4, 2008, Pages 471-477

  Hosokawa, Y ^a   Hosokawa, I ^a   Ozaki, K ^a   Nakae, H ^a   Matsuo, T ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CC chemokine ligand 17; CC chemokine receptor 4; Human gingival fibroblast; Periodontal disease

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; LIGAND; LIPOPOLYSACCHARIDE; PAM(3)CSK(4) PEPTIDE; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; ESCHERICHIA COLI; FIBROBLAST; GINGIVA; HUMAN; IMMUNOLOGY; PERIODONTAL DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CHEMOKINE CCL17; CYTOKINES; ESCHERICHIA COLI; FIBROBLASTS; GINGIVA; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIGANDS; LIPOPOLYSACCHARIDES; NF-KAPPA B; PEPTIDES; PERIODONTAL DISEASES; RECEPTORS, CCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 45549094798     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01080.x     Document Type: Article

References (42)

1. Dzink JL, Tanner AC, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 1985 12 : 648 659.
2. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol 1998 25 : 134 144.
3. Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol 1993 64 : 1013 1022.
4. Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J Periodont Res 1996 31 : 393 407.
5. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005 76 : 2033 2041.
6. Jotwani R, Cutler CW. Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res 2003 82 : 736 741.
7. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001 12 : 125 135.
8. Seymour GJ, Gemmell E, Reinhardt RA, Eastcott J, Taubman MA. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J Periodont Res 1993 28 : 478 486.
9. Taubman MA, Haffajee AD, Socransky SS, Smith DJ, Ebersole JL. Longitudinal monitoring of humoral antibody in subjects with destructive periodontal diseases. J Periodont Res 1992 27 : 511 521.
10. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000 164 : 2102 2109.
11. + T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 2002 128 : 548 554.
12. Hosokawa Y, Nakanishi T, Yamaguchi D, Nakae H, Matsuo T. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue. Clin Exp Immunol 2005 139 : 506 512.
13. Hosokawa Y, Hosokawa I, Ozaki K et al. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease. Clin Exp Immunol 2005 141 : 467 474.
14. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005 142 : 285 291.
15. Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts. Clin Exp Immunol 2007 149 : 146 154.
16. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997 272 : 15036 15042.
17. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998 187 : 129 134.
18. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999 11 : 81 88.
19. Katakura T, Miyazaki M, Kobayashi M, Herndon DN, Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 2004 172 : 1407 1413.
20. Sekiya T, Yamada H, Yamaguchi M et al. Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002 57 : 173 177.
21. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005 60 : 685 688.
22. Wenzel J, Henze S, Worenkamper E et al. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus. J Invest Dermatol 2005 124 : 1241 1248.
23. Yoneyama H, Harada A, Imai T et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 1998 102 : 1933 1941.
24. Kawasaki S, Takizawa H, Yoneyama H et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001 166 : 2055 2062.
25. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996 271 : 21514 21521.
26. Campbell JJ, Haraldsen G, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999 400 : 776 780.
27. Vestergaard C, Yoneyama H, Murai M et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999 104 : 1097 1105.
28. Sekiya T, Miyamasu M, Imanishi M et al. Inducible expression of a Th2-type CC chemokine thymus- and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 2000 165 : 2205 2213.
29. Reinhard C, Shamoon B, Shyamala V, Williams LT. Tumor necrosis factor α-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J 1997 16 : 1080 1092.
30. Westra J, Brouwer E, Bos R et al. Regulation of cytokine-induced HIF-1α expression in rheumatoid synovial fibroblasts. Ann N Y Acad Sci 2007 1108 : 340 348.
31. Yu B, Koga T, Urabe K et al. Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-α and IFN-γ in human keratinocyte and fibroblast. J Dermatol Sci 2002 30 : 29 36.
32. Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003 111 : 520 526.
33. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000 18 : 593 620.
34. Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001 97 : 367 375.
35. Hanazawa S, Kawata Y, Takeshita A et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993 61 : 5219 5224.
36. Gemmell E, Carter CL, Seymour GJ. Chemokines in human periodontal disease tissues. Clin Exp Immunol 2001 125 : 134 141.
37. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of interleukin-1β, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000 71 : 1535 1545.
38. Proost P, Vynckier AK, Mahieu F et al. Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-γ and provide a mechanism for enhanced synovial chemokine levels in septic arthritis. Eur J Immunol 2003 33 : 3146 3153.
39. Imanishi T, Hara H, Suzuki S, Suzuki N, Akira S, Saito T. Cutting edge: TLR2 directly triggers Th1 effector functions. J Immunol 2007 178 : 6715 6719.
40. Wu HJ, Sawaya H, Binstadt B et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med 2007 204 : 1911 1922.
41. Komine M, Kakinuma T, Kagami S, Hanakawa Y, Hashimoto K, Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005 125 : 491 498.
42. Heijink IH, Kies PM, Kauffman HF, Postma DS, van Oosterhout AJ, Vellenga E. Down-regulation of E-cadherin in human bronchial epithelial cells leads to epidermal growth factor receptor-dependent Th2 cell-promoting activity. J Immunol 2007 178 : 7678 7685.